Follow
J Timothy Greenamyre
J Timothy Greenamyre
Director, Pittsburgh Institute for Neurodegenerative Diseases, Professor & Vice-Chair of Neurology
Verified email at pitt.edu - Homepage
Title
Cited by
Cited by
Year
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet, TB Sherer, G MacKenzie, M Garcia-Osuna, AV Panov, ...
Nature neuroscience 3 (12), 1301-1306, 2000
45762000
Unified Huntington's disease rating scale: reliability and consistency
K Kieburtz, JB Penney, P Como, N Ranen, A Feigin, D Abwender, ...
Movement disorders 11 (2), 136-142, 1996
19761996
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
AV Panov, CA Gutekunst, BR Leavitt, MR Hayden, JR Burke, ...
Nature neuroscience 5 (8), 731-736, 2002
12392002
Mechanism of toxicity in rotenone models of Parkinson's disease
TB Sherer, R Betarbet, CM Testa, BB Seo, JR Richardson, JH Kim, ...
Journal of Neuroscience 23 (34), 10756-10764, 2003
12082003
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation
TB Sherer, JH Kim, R Betarbet, JT Greenamyre
Experimental neurology 179 (1), 9-16, 2003
9782003
A highly reproducible rotenone model of Parkinson's disease
JR Cannon, V Tapias, HM Na, AS Honick, RE Drolet, JT Greenamyre
Neurobiology of disease 34 (2), 279-290, 2009
8432009
Animal models of Parkinson's disease
R Betarbet, TB Sherer, JT Greenamyre
Bioessays 24 (4), 308-318, 2002
8222002
Alternative excitotoxic hypotheses
RL Albin, JT Greenamyre
Neurology 42 (4), 733-733, 1992
7781992
An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage
TB Sherer, R Betarbet, AK Stout, S Lund, M Baptista, AV Panov, ...
Journal of Neuroscience 22 (16), 7006-7015, 2002
7432002
Excitatory amino acids and Alzheimer's disease
JT Greenamyre, AB Young
Neurobiology of aging 10 (5), 593-602, 1989
6411989
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
R Di Maio, PJ Barrett, EK Hoffman, CW Barrett, A Zharikov, A Borah, X Hu, ...
Science translational medicine 8 (342), 342ra78-342ra78, 2016
5892016
Parkinson's--divergent causes, convergent mechanisms
JT Greenamyre, TG Hastings
Science 304 (5674), 1120-1122, 2004
5582004
NMDA receptor losses in putamen from patients with Huntington's disease
AB Young, JT Greenamyre, Z Hollingsworth, R Albin, C D'Amato, ...
Science 241 (4868), 981-983, 1988
5061988
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease
Huntington Study Group
Neurology 57 (3), 397-404, 2001
5012001
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking
AL Orr, S Li, CE Wang, H Li, J Wang, J Rong, X Xu, PG Mastroberardino, ...
Journal of Neuroscience 28 (11), 2783-2792, 2008
4812008
Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate-and kainate-sensitive glutamate binding sites.
JT Greenamyre, JM Olson, JB Penney, AB Young
Journal of Pharmacology and Experimental Therapeutics 233 (1), 254-263, 1985
4671985
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
AHV Schapira, CW Olanow, JT Greenamyre, E Bezard
The Lancet 384 (9942), 545-555, 2014
4512014
The role of environmental exposures in neurodegeneration and neurodegenerative diseases
JR Cannon, JT Greenamyre
Toxicological Sciences 124 (2), 225-250, 2011
4512011
Glutamate and Parkinson’s disease
F Blandini, RHP Porter, JT Greenamyre
Molecular neurobiology 12, 73-94, 1996
4461996
Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases
JT Greenamyre, JB Penney, AB Young, CJ D'Amato, SP Hicks, I Shoulson
Science 227 (4693), 1496-1499, 1985
4391985
The system can't perform the operation now. Try again later.
Articles 1–20